Cat# : THA-0118
Cat#: | THA-0118 |
Product Name: | Brolucizumab |
Description: | Brolucizumab is an anti VEGF-A monoclonal antibody indicated to treat neovascular age related macular degeneration. |
Sequences: | Not Available |
Molecular Weight: | 26000.0 Da (approximate) |
Introduction: | Brolucizumab, also known as RTH258 or ESBA1008, is a monoclonal antibody indicated to treat neovascular age related macular degeneration. Brolucizumab was granted FDA approval in October 2019. |
Purity: | >99% by SDS-Page and HPLC analysis |
Formula: | Not Available |
Appearance: | Solid |
For more information on how our products could help advance your project, please contact us.
ENTER YOUR EMAIL HERE TO SUBSCRIBE.
Copyright © 2024 Creative BioMart. All Rights Reserved.